Basics Recursion Pharmaceuticals, Inc. IPO Date: April 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.01B Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 3.89% Avg Daily Range (30 D): $0.15 | 2.59% Avg Daily Range (90 D): $0.16 | 3.19% Institutional Daily Volume Avg Daily Volume: 6M Avg Daily Volume (30 D): 17.33M Avg Daily Volume (90 D): 23.69M Trade Size Avg Trade Size (Sh.): 192 Avg Trade Size (Sh.) (30 D): 283 Avg Trade Size (Sh.) (90 D): 348 Institutional Trades Total Inst.Trades: 2,276 Avg Inst. Trade: $2.26M Avg Inst. Trade (30 D): $1.62M Avg Inst. Trade (90 D): $1.86M Avg Inst. Trade Volume: .27M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.75M Avg Closing Trade (30 D): $2.93M Avg Closing Trade (90 D): $3.78M Avg Closing Volume: 445.15K     News Aug 10, 2025 @ 9:20 AM 3 Brilliant Growth Stocks to Buy Now and Hold for ... Source: James Brumley Aug 5, 2025 @ 10:21 PM Why Recursion Pharmaceuticals Stock Tanked on Tues... Source: Eric Volkman Aug 3, 2025 @ 4:32 PM 2 Beaten-Down Stocks With Incredible Upside Potent... Source: Prosper Junior Bakiny Jul 30, 2025 @ 2:00 PM Drug Discovery Platforms Market Size Expected t... Source: Towards Healthcare Jul 26, 2025 @ 10:14 PM The Median Retirement Savings for American Househo... Source: James Brumley Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.82 $-.41 $-.5 Diluted EPS $-1.82 $-.41 $-.5 Revenue $ 64.6M $ 19.22M $ 14.75M Gross Profit $ -2.27M $ -.94M $ -7.08M Net Income / Loss $ -649.13M $ -171.9M $ -202.49M Operating Income / Loss $ -649.72M $ -176.23M $ -191.37M Cost of Revenue $ 66.86M $ 20.16M $ 21.83M Net Cash Flow $ 51.09M $ 24.69M $ -93.87M PE Ratio